← FDA DRUG APPROVALS

FDA ANDA · ANDA062994

AMPICILLIN SODIUM

Sponsor: WATSON LABS INC

APPLICATION
ANDA062994
TYPE
ANDA
ORIGINAL APPROVAL
1988-09-15
LATEST ACTION
2000-12-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMPICILLIN SODIUMDiscontinued
AMPICILLIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2000-12-08Manufacturing (CMC) · Supplement 19AP
1999-11-08Manufacturing (CMC) · Supplement 18AP
1997-12-29Manufacturing (CMC) · Supplement 17AP
1997-12-11Labeling · Supplement 15AP
1997-07-30Manufacturing (CMC) · Supplement 14AP
1996-04-17Manufacturing (CMC) · Supplement 13AP
1996-03-12Labeling · Supplement 11AP
1995-06-23Manufacturing (CMC) · Supplement 12AP
1995-01-27Manufacturing (CMC) · Supplement 10AP
1994-03-22Labeling · Supplement 4AP
1994-01-13Manufacturing (CMC) · Supplement 9AP
1993-11-19Manufacturing (CMC) · Supplement 7AP
1991-01-23Manufacturing (CMC) · Supplement 5AP
1988-12-07Manufacturing (CMC) · Supplement 2AP
1988-11-08Manufacturing (CMC) · Supplement 1AP
1988-09-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →